tirzepatide/pyridoxine compound Tirzepatide Injections Tirzepatide / Niacinamide Injection |

Zepbound and Mounjaro (tirzepatide): why the FDA put a warning on the label Tirzepatide has 2 active ingredients: GLP-1 / GIP dual agonists and the FDA labels for both Mounjaro (the diabetes formulation) and Zepbound (the chronic-weight-management formulation) carry an explicit drug-interaction note about oral hormonal contraceptives

Will order again

Treatment goals focus on glycemic control, weight management, and comprehensive cardiometabolic risk reduction rather than targeting inflammatory markers

The researchers who conducted the study compared the NAION rates among patients who started a GLP-1 versus those who started a dipeptidyl peptidase 4 inhibitor

in trial 2, the reduction was 29.3 versus 5.5 events per hour (difference -23.8, 95% CI -29.6 to -17.9